Related Experiment Videos
Circulating leptin in patients with chronic obstructive pulmonary disease
N Takabatake1, H Nakamura, S Abe
1First Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan.
Summary
Patients with chronic obstructive pulmonary disease (COPD) have lower serum leptin levels, which correlate with body mass and fat percentage. Leptin regulation in COPD cachexia appears independent of the tumor necrosis factor-alpha system.
Area of Science:
- Pulmonary Medicine
- Endocrinology
- Metabolic Research
Background:
- Unexplained weight loss and cachexia are prevalent in Chronic Obstructive Pulmonary Disease (COPD).
- Leptin, a key regulator of body weight and energy expenditure, has a potential role in COPD-related metabolic disturbances.
Purpose of the Study:
- To investigate serum leptin levels in COPD patients.
- To examine the relationship between leptin, body composition, and inflammatory markers like tumor necrosis factor-alpha (TNF-alpha) in COPD.
Main Methods:
- Compared serum leptin, TNF-alpha, and soluble TNF receptor (sTNF-R55, sTNF-R75) levels in 31 COPD patients and 15 healthy controls.
- Assessed body mass index (BMI) and percent body fat (%fat) in all participants.
- Analyzed correlations between leptin, BMI, %fat, and inflammatory markers.
Main Results:
- COPD patients exhibited significantly lower BMI, %fat, and serum leptin levels compared to controls.
- COPD patients showed significantly higher serum TNF-alpha, sTNF-R55, and sTNF-R75 levels.
- Leptin levels correlated positively with BMI and %fat but showed no correlation with TNF-alpha or sTNF-R levels in COPD patients.
Conclusions:
- Circulating leptin levels are reduced in COPD patients with cachexia.
- Leptin regulation in COPD cachexia is physiologically maintained and independent of the TNF-alpha system.